Health & Disease Management Service Summary

Research Overview

The Health & Disease Management Service is an ongoing research project that focuses on health and disease management initiatives within significant managed care customer segments. This research provides benchmarking profiles of manufacturer, disease management organization and PBM disease management program investment across the commercial HMO, Medicare and employer segments.  The service also includes in-depth case studies that highlight the key components of disease management program collaborations between pharmaceutical manufacturers and health plans.

Who Should Subscribe?

Health management executives, sales support, brand managers, disease management program managers, managed markets managers, and account managers who want to successfully implement disease management programs to improve patient outcomes and promote appropriate utilization. 

Why Subscribe?

HIRC research assists pharmaceutical executives in positioning DM programs that meet the needs of their customers. The service examines the manufacturer benefits of disease management program investment including:

• Acquiring key strategic information to advance disease management efforts
• Increasing market share of their products upon program adoption
• Increasing patient compliance through appropriate use of medication
• Enhancing the formulary position for their products and providing a competitive edge over other brands
• Improving strategic relationships with managed care organizations, as well as employer coalitions and Medicare Advantage plans
• Promoting physician access to disease management programs for their patients